Dr. Kabarriti is on Doximity
As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.
- Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
- Connect with colleagues in the same hospital or clinic.
- Read the latest clinical news, personalized to your specialty.
Office
111 E 210th St
Bronx, NY 10467Phone+1 718-920-7750
Education & Training
Albert Einstein College of MedicineClass of 2010
Certifications & Licensure
NY State Medical License 2015 - 2026
American Board of Radiology Radiation Oncology
Clinical Trials
- Phase III Xevinapant (Debio 1143) and Radiotherapy in Resected LA SCCHN, High Risk, Cisplatin-ineligible Participants (XRAY VISION) Start of enrollment: 2022 Oct 06
Roles: Principal Investigator
- Therapy Adapted for High Risk and Low Risk HIV-Associated Anal Cancer Start of enrollment: 2022 Aug 09
Roles: Contact, Principal Investigator
- Phase 1b Safety Study of Xevinapant, Weekly Cisplatin, and RT in Participants With Unresected LA SCCHN (HyperlynX) Start of enrollment: 2024 Jan 18
Roles: Principal Investigator
Publications & Presentations
PubMed
- Randomized Evaluation of the PET-Adjusted IMRT for NSCLC Trial (REPAINT).Nitin Ohri, William R Bodner, Rafi Kabarriti, Viswanathan Shankar, Rasim Gucalp
International Journal of Radiation Oncology, Biology, Physics. 2025-01-23 - Evaluating Tumor Tissue Modified Viral (TTMV)-HPV DNA for the Early Detection of Anal Squamous Cell Carcinoma Recurrence.Rafi Kabarriti, Shane Lloyd, James Jabalee, Catherine Del Vecchio Fitz, Randa Tao
Cancers. 2025-01-08 - Association of tumor growth rate with overall survival and recurrence among patients with laryngeal squamous cell carcinoma.Faye G Zhang, Shankar Viswanathan, Chenxin Zhang, Richard V Smith, Bradley A Schiff
Head & Neck. 2025-01-01
Journal Articles
- Radiation Therapy for Patients with Newly Diagnosed Metastatic Head and Neck Squamous Cell CarcinomaRafi Kabarriti, Nitin Ohri, Chandan Guha, Madhur K Garg, Sujith Baliga, Shalom Kalnicki, Head & Neck
- Utilization of Transoral Robotic Surgery (TORS) in Patients with Oropharyngeal Squamous Cell Carcinoma and Its Impact on Survival and Use of ChemotherapySujith Baliga, Julie Jiang, Chandan Guha, Rafi Kabarriti, Madhur K Garg, Shalom Kalnicki, Richard V Smith, Vikas Mehta, ScienceDirect
Press Mentions
No Race Difference Found in COVID-19 Mortality Rates at Same Medical CenterSeptember 30th, 2020- Un Estudio Determina La No Disparidad Racial Entre Las Tasas De Mortalidad en Casos De COVID-19 en Montefiore, Al Controlar Los Factores De Riesgo ClaveSeptember 25th, 2020
Cancer Patients Face High Mortality from COVID-19May 4th, 2020- Join now to see all
Viewing the full profile is available to verified healthcare professionals only.
Find your profile and take control of your online presence:
